NCT00353119View on ClinicalTrials.gov

A Placebo-Controlled Double-Blind Study on the Safety and Efficacy of Etanercept in Palmoplantar Pustulosis

PHASE3CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

March 31, 2007

Study Completion Date

March 31, 2007

Conditions
Palmoplantaris Pustulosis
Interventions
DRUG

Placebo comparator

Patients received placebo subcutaneously twice weekly

DRUG

Etanercept

Patients received etanercept 50 mg subcutaneously twice weekly

Trial Locations (3)

H7S 2C6

Innovaderm Research Incorporated, Laval

H2K 4L5

Innovaderm Research Incorporated, Montreal

G1V 4X7

Centre de Recherche Dermatologique du Québec métropolitain, Québec

Sponsors

Collaborators (1)

Amgen
All Listed Sponsors
collaborator

Amgen

INDUSTRY

lead

Innovaderm Research Inc.

OTHER